The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.
- Past awards
- 21
- 21 new
- Median first-year cost
- $229,800
- $4,735,855 in all
- Institutions
- 16
- 21 contact PIs
- Patents
- 4
- from 4 funded projects
Awards by fiscal year
0
0
0
7
6
8
0
0
0
0
0
0
0
14151617181920212223242526
Fiscal years 2014 to 2026.
Most frequent institutions
- UNIVERSITY OF MICHIGAN AT ANN ARBOR3
- EMORY UNIVERSITY2
- MASSACHUSETTS GENERAL HOSPITAL2
- STANFORD UNIVERSITY2
- BOSTON UNIVERSITY (CHARLES RIVER CAMPUS)1
and 11 other institutions
Most frequent study sections
- Special Emphasis Panel (ZHL1 CSR-O (M1))7
- Special Emphasis Panel (ZHL1 CSR-Q (O2))6
- Special Emphasis Panel (ZHL1 CSR-P (F1))4
- Special Emphasis Panel (ZHL1 CSR-O (O1))2
- Special Emphasis Panel (ZHL1 CSR-Q (F1))2
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| FY2019 | Using a Cardiac Microtissue System to Evaluate and Replicate Clinical Therapy Responses using Patient Cell-Derived Exosomes1R21HL144244-01 | Taylor, Doris A | TEXAS HEART INSTITUTE, TX | First-year cost $244,500 | Study section ZHL1 |
| FY2019 | Engineered Protein Oxygen Carriers: a novel blood substitute for trauma care1R21HL144224-01 | Moser, Christopher LSims, Carrie Adelia | UNIVERSITY OF PENNSYLVANIA, PA | First-year cost $242,625 | Study section ZHL1 |
| FY2019 | A New Pacing Approach for Cardioprotection and Repair in Heart Failure1R21HL144199-01 | Hodgson-Zingman, Denice | UNIVERSITY OF IOWA, IA | First-year cost $241,160 | Study section ZHL1 |
| FY2019 | Cryo-ET structural studies of platelets1R21HL146299-01 | Li, RenhaoWright, Elizabeth R | EMORY UNIVERSITY, GA | First-year cost $234,000 | Study section ZHL1 |
| FY2019 | ECM Shrink Wrapped Human Cardiomyocytes and Endothelial Cells to Accelerate Myocardial Regeneration1R21HL144235-01 | Feinberg, Adam Walter | CARNEGIE-MELLON UNIVERSITY, PA | First-year cost $214,518 | Study section ZHL1 |
| FY2019 | Multi-functional targeted bio-conjugate platform to dismantle neutrophil extracellular traps (NETs)1R21HL144253-01 | Grinstaff, Mark W.Herrera, Victoria LRuiz-Opazo, Nelson | BOSTON UNIVERSITY (CHARLES RIVER CAMPUS), MA | First-year cost $206,250 | Study section ZHL1 |
| FY2019 | Extracellular Matrix-Derived Nanoparticles for Repairing Lung Injury1R21HL146250-01 | Heise, Rebecca Long | VIRGINIA COMMONWEALTH UNIVERSITY, VA | First-year cost $181,005 | Study section ZHL1 |
| FY2019 | Optical Mapping of Cardiac Electromechanics in the In Vivo Setting1R21HL140998-01A1 | Rogers, Jack M | UNIVERSITY OF ALABAMA AT BIRMINGHAM, AL | First-year cost $178,738 | Study section ZHL1 |
| FY2018 | Portable CO2 servoregulation system for membrane lungs1R21HL140995-01 | Potkay, Joseph Allen | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | First-year cost $233,500 | Study section ZHL1 |
| FY2018 | Point of Care Testing to Improve Monitoring of LVAD Patients1R21HL141028-01 | Chilkoti, AshutoshFranklin, AaronRogers, Joseph G. | DUKE UNIVERSITY, NC | First-year cost $229,922 | Study section ZHL1 |
| FY2018 | Optical Pacing Using Graphene-Cardiomyocyte Interfaces for Precision Medicine and Drug Discovery1R21HL141019-01 | Mercola, Mark | STANFORD UNIVERSITY, CA | First-year cost $229,800 | Study section ZHL1 |
| FY2018 | Superomniphobic flow controlled prosthetic heart valve1R21HL139208-01 | Dasi, Lakshmi PrasadKota, Arun KumarPopat, Ketul Chandrakant | OHIO STATE UNIVERSITY, OH | First-year cost $228,830 | Study section ZHL1 |
| FY2018 | Rapid breath analysis for acute respiratory distress syndrome diagnostics1R21HL139156-01 | Fan, Xudong | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | First-year cost $225,166 | Study section ZHL1 |
| FY2018 | Potentials of a Newly Engineered Device for Treatment of Neonatal Thrombocytopenia1R21HL141016-01 | Wu, Mei X | MASSACHUSETTS GENERAL HOSPITAL, MA | First-year cost $211,574 | Study section ZHL1 |
| FY2017 | Utility of Vagal Stimulation to Prevent the Onset of Ventricular Arrhythmias1R21HL137870-01 | Armoundas, Antonis A | MASSACHUSETTS GENERAL HOSPITAL, MA | First-year cost $254,921 | Study section ZHL1 |
| FY2017 | Engineered Protein Hydrogels to Modulate Adipose-derived Stromal Cell Secretome and Exosomes for Injectable Myocardial Infarction Therapy1R21HL138042-01 | Heilshorn, Sarah C | STANFORD UNIVERSITY, CA | First-year cost $235,890 | Study section ZHL1 |
| FY2017 | PET Imaging Probes Targeting Cardiac Parasympathetic Innervation1R21HL138054-01 | Raffel, David M | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | First-year cost $232,625 | Study section ZHL1 |
| FY2017 | Cerebral Diffusion: A new approach to sleep disorders1R21HL138075-01 | Dubowitz, David | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | First-year cost $232,500 | Study section ZHL1 |
| FY2017 | Use of a Variable Dead Space Rebreathe Device (Smart CO2) to Treat Obstructive and Central Sleep Apnea1R21HL137874-01 | Dempsey, Jerome A | UNIVERSITY OF WISCONSIN-MADISON, WI | First-year cost $229,500 | Study section ZHL1 |
| FY2017 | Microvascular Cerebral Blood Flow Measured with Diffuse Correlation Spectroscopy in Children with Sickle Cell Disease1R21HL138062-01 | Buckley, Erin McGuire | EMORY UNIVERSITY, GA | First-year cost $224,581 | Study section ZHL1 |
| FY2017 | Bioengineered peptibodies as antiarrhythmic therapy in atrial fibrillation1R21HL138064-01 | Noujaim, Sami Fouad | UNIVERSITY OF SOUTH FLORIDA, FL | First-year cost $224,250 | Study section ZHL1 |
Newest fiscal year first, then first-year cost.
Patents from its funded projects
4 patents name 4 of the 21 funded projects.
- US 12,281,161 (opens the patent at USPTO, a PDF, in a new tab)NOVEL POLYPEPTIDES AND USES THEREOFGranted April 22, 2025 to Trustees of Boston UniversityR21HL144253 · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS), MA
- US 12,233,189 (opens the patent at USPTO, a PDF, in a new tab)Smart Artificial Lung And Perfusion SystemsGranted February 25, 2025 to THE REGENTS OF THE UNIVERSITY OF MICHIGAN and The United States Government as Represented by the Department of Veterans AffairsR21HL140995 · UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI
- US 11,014,971 (opens the patent at USPTO, a PDF, in a new tab)Peptibodies for the treatment of atrial fibrillationGranted May 25, 2021 to University of South FloridaR21HL138064 · UNIVERSITY OF SOUTH FLORIDA, FL
- US 10,442,166 (opens the patent at USPTO, a PDF, in a new tab)Hydrophilic, Yet Slippery SurfacesGranted October 15, 2019 to Colorado State University Research FoundationR21HL139208 · OHIO STATE UNIVERSITY, OH
Each number opens the patent at USPTO, beside the project NIH ties it to and that project's institution. NIH ties a patent to a project, not to a year of its funding, and says its list is incomplete. The grant date and the owners are USPTO's: the organizations the patent names as assignees on the day it was granted. Source: United States Patent and Trademark Office, www.uspto.gov, which does not endorse ScienceDex.
Data: Grants.gov's daily extract and NIH's notice pages, award files and patents file, in ScienceGraph release conductgrants-2026-11-13-0.3.2. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.